Skip to main content

Month: June 2020

Earth Alive Grants Stock Options and Confirms Record Date

MONTREAL, June 12, 2020 (GLOBE NEWSWIRE) — Earth Alive Clean Technologies Inc. (TSXV: EAC) (the “Company”), a Canadian soil health company that develops and manufactures advanced microbial technology products announces that, on June 8, 2020, it has granted stock options to purchase a total of 2,000,000 common shares of the Company to certain senior officers of the Company. The options are exercisable at a price of $0.11 per share and have a term of five years.These options vest over a period of twenty-four months following the grant date and have been granted in accordance with the Corporation’s stock option plan.As well, to clarify, on page 4 of the management information circular of the Company provided in connection with the Annual General Meeting of the shareholders of the Company to be held on June 30, 2020, the record date...

Continue reading

Innovative Humane Restraint Provides Solutions for Police Reform

NEW YORK, June 12, 2020 (GLOBE NEWSWIRE) — via NetworkWire — Wrap Technologies Inc. (NASDAQ: WRTC) today announces its placement in an editorial published by NetworkNewsWire (“NNW”).To view the full publication, “Behavioral Training, Humane Restraint Invaluable Options for Law Enforcement During Calls for Systemic Reform,” visit: http://nnw.fm/k9qDU.Law enforcement agencies around the country have moved procedures, training and safety to top priorities in response to the national outcry for police reform. A passionate public is demanding that law enforcement agencies find new, humane approaches to prevent the abuse of power and authority as a sweeping police reform bill to ban chokeholds and no-knock warrants makes its way through Congress. At the same time, law enforcement across the country are searching for and deserve...

Continue reading

Datametrex Received the Final Payment on Completed Shipping of COVID-19 Test Kit Order

TORONTO, June 12, 2020 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that the Company has received the full and final payment from its purchaser and completed shipping the first purchase order (the “PO”) of COVID-19 test kits for a mining company employees in multiple jurisdictions outside of Canada, as announced on May 15th2020.The total gross sales amount is approximately $500,000 CDN, excluding shipping.Under the terms of the PO, Datametrex sold to the purchaser an initial 10,000 units of the iONEBIO Inc. iLAMP Novel-CoV19 Detection Kit; 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples....

Continue reading

Grace Announces Proposed Private Offering of Senior Notes

COLUMBIA, Md., June 12, 2020 (GLOBE NEWSWIRE) — W. R. Grace & Co. (NYSE:GRA) (“Grace”) announced today that its wholly owned subsidiary, W. R. Grace & Co.-Conn (the “Issuer”), intends to offer $550 million in aggregate principal amount of senior unsecured notes due in 2027 (the “New Notes”), subject to market and other customary conditions. The New Notes will be fully and unconditionally guaranteed by Grace and certain of its existing and future domestic subsidiaries. The New Notes and the related guarantees will be offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to non-U.S. persons in accordance with Regulation S under the Securities Act.The Issuer expects to use the net proceeds from the offering to redeem a portion of its existing...

Continue reading

Revive Therapeutics Expands Research Partnership for Novel Formulation Development and Clinical Research of Psilocybin with the University of Wisconsin-Madison

TORONTO, June 12, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an expansion to the sponsored research partnership agreement (“SRPA”) entered with the University of Wisconsin-Madison to evaluate novel formulations of psilocybin and a Phase 1 clinical study investigating the therapeutic application of psilocybin for an undisclosed addiction use disorder.“We are pleased to have expanded our research partnership with the University of Wisconsin-Madison in the development of novel psilocybin formulations that will serve as the platform to create unique psychedelic-based therapeutics for clinical research targeting specific medical needs, such...

Continue reading

PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service

RALEIGH, N.C., June 12, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the enhancement of its commercial Health Harmony COVID-19 Monitoring Program with the integration of the Microsoft Healthcare Bot service. Users of PRA’s Health Harmony digital platform who enroll in their organization’s COVID-19 Monitoring Program can use the AI-based chatbot, which can recognize and respond to COVID-19-related questions, to enhance their own COVID-19 care.Through a series of conversational questions and interactions within PRA’s Health Harmony digital health platform, the COVID-19 chatbot compares users’ symptoms to U.S. Centers for Disease Control guidance and then recommends one of three available COVID-19 programs in which they should enroll. For users of the Health Harmony app, the enrollment experience...

Continue reading

PRA集成Microsoft Healthcare Bot服务以增强新冠肺炎监控计划

北卡罗来纳州罗利市, June 12, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH )今天宣布,将通过集成Microsoft Healthcare Bot服务提升其商业性Health Harmony新冠肺炎监控计划。PRA的Health Harmony数字平台用户如果参与了其所在组织的新冠肺炎监控计划,即可以使用基于人工智能技术并可识别和回复新冠肺炎相关问题的聊天机器人,从而提升自己的新冠肺炎相关医护水平。通过PRA的Health Harmony数字健康平台中一系列会话式问题和互动,新冠肺炎聊天机器人将用户症状与美国疾病控制中心指南进行对比,然后从三项现有的新冠肺炎计划中推荐一项供用户加入。对于Health Harmony应用程序的用户,注册体验变得更加个性化,并且能更准确地确定用户所需的新冠肺炎医护等级。对于已实施PRA新冠肺炎监控计划的组织而言,这项集成使其能够了解患者流,并能够以更高的敏捷性进行监控、教育和实现医疗个性化。“通过与Microsoft这样的前沿领先企业密切合作,PRA获得了独特的有利条件,能够随着患者需求的不断变化为其提供创新性的医疗新模式,在危机和不确定时期尤其如此”,PRA Health Sciences执行副总裁兼首席科学官Kent Thoelke表示。“通过PRA的Health Harmony应用,患者可以跟踪体征、症状,并对新冠肺炎相关护理进行自我管理,但如果症状升级,远程监护和医疗专业人员的帮助则至关重要。PRA为患者提供更多的控制和获取个性化医疗更佳渠道,患者通过自己的设备即可根据他们自己的日程安排获取服务。”上个月,PRA面向美国7000多名雇员推出了集成新冠肺炎Healthcare Bot服务的这项计划,以及Health Harmony应用程序。自3月以来,世界各地已有数千名用户下载了PRA的Health Harmony应用程序,并加入了新冠肺炎监控计划。作为计划的一部分,用户可跟踪自己的新冠肺炎症状并获取有关这一疾病的相关知识。新冠肺炎监控计划(面向雇主、支付方、医疗服务提供方和医疗系统)提供三级支持:教育计划,针对无症状者,提供生命体征跟踪、预防技术和心理健康支持。隔离计划,针对新冠肺炎接触者,提供有关密切关注事项的见解,应对恐惧感和孤立感,并联系医护人员。深度监控计划,针对仍然居家的新冠肺炎确诊者,涉及症状处置、由医护人员执行的经常性监测,以及医疗协调。“医疗保健和临床研究应可供所有人便捷利用,并适合其各自的独特需求,”...

Continue reading

PRA 透過整合 Microsoft Healthcare Bot Service 增強 COVID-19 監測計劃

北卡羅萊納州拉里市, June 12, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) 今天宣佈透過整合 Microsoft Healthcare Bot 服務來增強其商業 Health Harmony COVID-19 監測計劃。PRA Health Harmony 數碼平台用戶如登記所屬組織的 COVID-19 監測計劃,將可使用採用人工智能技術的對話機械人,該程式可識別並回答與 COVID-19 相關的問題,藉此改善 COVID-19 護理。透過 PRA 的 Health Harmony 數碼健康平台的一系列對話問題和互動,COVID-19 對話機械人可將用戶的症狀與美國疾病控制中心的指引進行比較,然後建議用戶從三個可用的 COVID-19 計劃中選擇應參加哪一個。對於 Health Harmony 應用程式的用戶,登記體驗變得更加個人化,而且在斷定所需的 COVID-19 護理水平方面更為準確。對於已實施 PRA 的 COVID-19 監測計劃的組織,該整合計劃將讓他們得以了解患者的病情,並以更高的敏捷度來監察、教育和提供個人化護理。PRA Health Sciences 執行副總裁兼首席科學總監 Kent Thoelke 表示:「PRA 透過與 Microsoft 等領先公司緊密合作,將可根據患者的需求作出變化,特別是在危機和不確定性時代中,為患者提供創新的新型護理模式。患者有了 PRA 的 Health Harmony 應用程式,即可追蹤生命體徵、症狀等數據,並自行管理與 COVID-19 相關的護理,即使症狀一旦惡化,遠端監察和醫療護理專業人士的幫助將發揮顯著成效。透過患者自己的裝置和時間表,PRA 可以直接讓患者掌握更大控制權並改善存取個人化的醫療服務。」PRA 在上月向美國 7,000 多名員工推出了該項計劃以及 Health Harmony 流動應用程式,同時配合...

Continue reading

PRA améliore son programme de suivi de la maladie COVID-19 avec l’intégration du service Microsoft Healthcare Bot

RALEIGH, Caroline du Nord, 12 juin 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd’hui l’amélioration de son programme commercial de suivi de la maladie COVID-19 Health Harmony avec l’intégration du service Microsoft Healthcare Bot. Les utilisateurs de la plateforme numérique Health Harmony de PRA qui s’inscrivent au programme de suivi de la maladie COVID-19 de leur entreprise peuvent utiliser le chatbot tirant parti de l’IA, qui est capable de reconnaître et de répondre aux questions liées à la maladie COVID-19, pour améliorer leurs propres soins de celle-ci.Grâce à une série de questions et d’interactions conversationnelles au sein de la plateforme de santé numérique Health Harmony de PRA, le chatbot COVID-19 compare les symptômes des utilisateurs aux directives...

Continue reading

PRA erweitert das COVID-19-Überwachungsprogramm durch die Integration des Microsoft Healthcare Bot-Dienstes

RALEIGH, NC (USA), June 12, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) hat heute die Erweiterung seines kommerziellen COVID-19-Überwachungsprogramms „Health Harmony“ durch die Integration des Microsoft Healthcare Bot-Dienstes bekanntgegeben. Benutzer der digitalen Health Harmony-Plattform von PRA, die sich für das COVID-19-Überwachungsprogramm ihres Unternehmens anmelden, können den KI-basierten Chatbot verwenden, der COVID-19-bezogene Fragen erkennen und beantworten kann, um ihre eigene Versorgung in Bezug auf COVID-19 zu verbessern.Durch eine Reihe von Konversationsfragen und Interaktionen auf der digitalen Health Harmony-Gesundheitsplattform von PRA vergleicht der COVID-19-Chatbot die Symptome der Benutzer mit den Anleitungen des US-amerikanischen Center for Disease Control und empfiehlt dann eines von drei...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.